Fortis Malar Hospitals Limited has notified BSE Limited of an upcoming Board of Directors meeting, scheduled for Monday, May 18, 2026. The meeting has been convened to consider and approve the audited financial results — both standalone and consolidated — for the quarter and financial year ended March 31, 2026. The intimation, bearing reference number FMHL/SEC/MAY'2026, was submitted on May 11, 2026, in accordance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details

The following key details have been disclosed regarding the scheduled board meeting:

Trading Window Closure

In continuation of the company's earlier communication — reference letter FMHL/SEC/2025-26 dated December 22, 2025 — regarding the closure of the trading window, Fortis Malar Hospitals has reiterated that the trading window for dealing in the company's securities will remain closed until 48 hours after the announcement of the financial results, which translates to up to May 20, 2026. This measure is in keeping with standard regulatory requirements applicable to listed entities ahead of material financial disclosures.

The notice has been signed by Vinti Verma, Company Secretary and Compliance Officer (Membership No.: A44528), on behalf of Fortis Malar Hospitals Limited.

Fortis malar hospitals Limited has submitted its quarterly compliance certificate under SEBI regulations for the quarter ended March 31, 2026. The healthcare company filed the mandatory certificate with BSE Limited on April 8, 2026, ensuring adherence to regulatory requirements for depositories and participants.

Regulatory Compliance Filing

The certificate was submitted pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018. Company Secretary and Compliance Officer Vinti Verma signed and filed the document with BSE Limited's Department of Corporate Services on April 8, 2026.

Registrar and Transfer Agent Certificates

KFin Technologies Limited, formerly known as KFin Technologies Private Limited, serves as the company's Registrar and Transfer Agent. The firm issued certificates to both major depositories on April 1, 2026, confirming compliance with regulatory requirements.

Depository Confirmations

Rajitha Cholleti, Vice President at KFin Technologies Limited, signed certificates addressed to:

• Central Depository Services (India) Limited (CDSL) - Marathon Futurex, Lower Parel, Mumbai
• National Securities Depository Limited (NSDL) - Trade World, Lower Parel, Mumbai

Both certificates confirm that details of securities dematerialized and rematerialized during the quarter ended March 31, 2026, have been furnished to all stock exchanges where Fortis Malar Hospitals Limited shares are listed.

Company Information

Fortis Malar Hospitals Limited operates with its registered office located at Fortis Hospital, Sector 62, Phase VIII, Mohali. The company maintains its corporate identification number as L85110PB1989PLC045948 and conducts business under the healthcare sector.

The quarterly filing represents standard regulatory compliance for listed companies, ensuring transparency in securities transactions and maintaining investor confidence through proper documentation and reporting procedures.